FREE EMBRYONIC DNA LEVELS IN THREATENED RECURRENT MISCARRIAGE AND UNCOMPLICATED PREGNANCY AT LESS THAN 22 WEEKS' GESTATION


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective. To make a comparative analysis of the peripheral blood levels of free embryonic DNA (fe-DNA) in women with threatened recurrent miscarriage and healthy pregnant women at 6 to 22 weeks’ gestation. Subjects and methods. A prospective cohort study was conducted in 57 pregnant women, including 33 women with recurrent miscarriage and 24 with an uncompromised obstetric and gynecological history. Regardless of fetal gender, fe-DNA was determined by a real-time polymerase chain reaction assay at a 2-week interval. Results. The clinical manifestations of threatened and incipient abortion were found to be related to high fe-DNA levels without regard to a patient’s history. In the women with recurrent miscarriage and an uncomplicated course of the first half of pregnancy, the levels of fe-DNA were established to be significantly higher than those in healthy pregnant women, which may predispose to placenta-related gestational complications. Conclusion. This data should be further analyzed to clarify the role of these changes in the implementation of the later gestational complications and possibilities of their use in clinical practice.

Texto integral

Acesso é fechado

Sobre autores

Nane Parsadanyan

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: nnnpars@mail.ru
Graduate student, Department of Pregnancy Loss Prevention and Therapy Moscow 117997, Ac. Oparina str. 4, Russia

Ekaterina Shubina

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: e_shubina@oparina4.ru
Graduate student, laboratory of molecular genetic methods Moscow 117997, Ac. Oparina str. 4, Russia

Nana Tetruashvili

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: tetrauly@mail.ru
MD, Head of the Department of Pregnancy Loss Prevention and Therapy Moscow 117997, Ac. Oparina str. 4, Russia

Dmitrii Trofimov

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: d_troflmov@oparina4.ru
Ph.D. in biological sciences, Head of Laboratory of molecular genetic methods Moscow 117997, Ac. Oparina str. 4, Russia

Gennady Sukhikh

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: gtsukhikh@mail.ru
MD, Professor, Academician of Russian Academy of Medical Sciences, Director Moscow 117997, Ac. Oparina str. 4, Russia

Bibliografia

  1. Lo Y.M., Leung T.N., Tein M.S., Sargent I.L., Zhang J., Lau T.K. et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin. Chem. 1999; 45(2): 184-8.
  2. Rusterholz C., Messerli M., Hoesli I., Hahn S. Placental microparticles, DNA, and RNA in preeclampsia. Hypertens. Pregnancy. 2011; 30: 364-75.
  3. Farina A., LeShane E.S., Romero R., Gomez R., Chaiworapongsa T., Rizzo N., Bianchi D.W. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am. J. Obstet. Gynecol. 2005; 193(2): 421-5.
  4. Sekizawa A., Jimbo M., Saito H., Iwasaki M., Sugito Y., Yukimoto Y. et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin. Chem. 2002; 48(2): 353-4.
  5. Lo Y.M., Corbetta N., Chamberlain P.F., Rai V., Sargent I.L., Redman C.W., Wainscoat J.S. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997; 350(9076): 485-7.
  6. Hahn S., Chitty L.S. Non-invasive prenatal diagnosis: current practice and future perspectives. Curr. Opin. Obstet. Gynecol. 2008; 20(2): 146-51.
  7. Chitty L., Daniels G., Finning K., Hogg J., Mistry B., Norbury G. et al. Prospective register of outcomes of free fetal DNA testing (PROOF) - results of the first year’s audit. J. Med. Genet. 2007; 44(Suppl. 1): S28.
  8. Fernandez-Martinez F.J., Galindo A., Garcia-Burguillo A., Vargas-Gallego C., Nogues N., Moreno-Garcia M., Moreno-Izquierdo A. Noninvasive fetal sex determination in maternal plasma: a prospective feasibility study. Genet. Med. 2012; 14(1): 101-6.
  9. Hill M., Taffinder S., Chitty L.S., Morris S. Incremental cost of non-invasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England. Prenat. Diagn. 2011; 31(3): 267-73.
  10. Carp H.J.A., ed. Recurrent pregnancy loss: causes, controversies and treatment. London: Informa Healthcare; 2007. 290 p.
  11. Klug W.S., CummingsM.R., Spencer C.A., Palladino M.A. Essentials of genetics. Publisher: Benjamin Cummings; 2009. 600 p.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2015

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies